We have reported that mouse embryonic stem (ES) cells transfected with insulin-like growth factor (IGF) II differentiated into mature skeletal muscle cells in vitro and in vivo after transplantation. On the contrary, IGFII transfected human induced pluripotent stem (hiPS) cells did not demonstrate mature skeletal muscle differentiation. The morphogenic factor Sonic Hedgehog (SHH) was suggested to upregulate the myogenic process along with IGF through Phosphoinositide 3 kinase (PI3K)/Akt signaling pathway. We cultured hiPS cells with SHH to generate myoblasts and transplanted the cells to hind limbs of mice.
Introduction
The myogenesis of satellite cells, a skeletal muscle stem cell population, is regulated by the paired box proteins Pax3 1) , Pax7 2) , and the MyoD family of transcriptional factors, such as MyoD, Myf5, and myogenin. Besides the essential myogenic factors, insulin-like growth factors (IGF) I and II promote myoblast proliferation and differentiation in autocrine/ paracrine fashion through activation of phosphoinositol-3 kinase (PI3K)/Akt pathway 3)4) . We previously reported that transfection of IG-FII gene into mouse embryonic stem (ES) cells led to differentiation into skeletal muscle cells 5) . We then transplanted the skeletal muscle cells into the injured muscles of mice and ameliorated the motor dysfunction.
Human iPS (hiPS) cells have proliferative, selfrenewal, and differentiation capacities that are similar to those of human ES cells 6) . We transduced hiPS cells with IGFII and Pax7 genes to generate human skeletal muscle cells and successfully induced early phase myogenesis that responded well to IGFII supplementation. However, these cells did not express In some experiments, insulin-like growth factor (IGF)II and sonic hedgehog (SHH) were supplemented into the dishes.
Immunocytochemistry and RT-PCR were conducted as described.
late phase skeletal muscle markers and showed low viability 7)9)
. We then cultured hiPS cells with a skeletal muscle cell growth medium after embryoid body (EB) formation to regulate the rapid differentiation of the cells 9) . We improved the dysregulated cell commitment and low viability to some extent but even the culture condition did not promote the myoblast maturation 7) . The Hedgehog family of morphogens play a central role in the development of vertebrate and in vertebrate embryos 10) . Sonic Hedgehog (SHH) promotes the generation of myotomal cell lineage in the embryo and upregulates the proliferation and differentiation of myoblasts 12) . In this study, we assessed whether SHH supplementation regulated the rapid myogenesis of hiPS cells and enabled the myoblasts to survive functionally in the mouse muscle.
Materials and Methods
Cell Culture (Fig. 1) We used the same hiPS cell line (253G1, RIKEN, Tsukuba, Japan) in this study as in our previous study 5) . Undifferentiated hiPS cells were maintained in growth medium consisting of DMEM/F12 supplemented with non-essential amino acids, pyruvate, 0.1 mM β-mercaptoethanol, 2 mM L-glutamine (all purchased from Gibco, Grand Island, NY), 20% Knockout serum replacement (KSR, Gibco), and basic fibroblast growth factor (bFGF, R&D Systems, Minneapolis, MN). The cells were cultured on mitomycin C-treated mouse embryonic fibroblasts (MEF) as a feeder layer.
We first developed EB from undifferentiated hiPS cells in a floating condition with growth medium for 4 days (from Day 0 to Day 4). Then the cells from EB were cultured in fibronectin (FN) coated dishes with a Skeletal Muscle Cell Growth Medium (PromoCell GmbH, Heidelberg, Germany), containing 20% fetal calf serum, 50 μg/ml bovine fetuin, a liver secretory glycoprotein, 10 ng/ml recombinant human epidermal growth factor, 1 ng/ml recombinant human bFGF, 10 μg/ml recombinant human insulin, and 0.4 μg/ml dexamethasone, for up to 7 days (from Day 5 to Day 11) (Fig. 1) . In several cell culture assays, we introduced recombinant human IGFII (200 ng/ml, Wako Pure Chemical, Osaka, Japan) and/or SHH (2 μg/ml, R&D systems) into the dishes daily until transplantation or immunocytochemistry analysis.
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)
The methods of total RNA extraction, cDNA synthesis and PCR amplification have been previously described 12) . The primers used in this study were reported already 14) 15) , except for the following; MyoD (148bp), sense gctctgatggcatgatggattacagcg, and antisense atgctggacaggcagtcgaggc. myogenin (85bp), sense caaccaggaggagcgcgatctccg, and antisense aggcgctgtgggagttgcattcact.
MRF4 (235bp), sense ctacattgagcgtctacaggacc, and antisense ctgaagactgctggaggctg. dystrophin (201 bp), sense ctctgcaaagttctttgaaagagcaa and antisense gaagtttattcatatgttcttctagc; Amplification of distilled water was used as a negative control and cDNA of human skeletal muscle cells (ScienCell Research Laboratories, Carlsbad, CA) was used as a positive control.
Immunofluorescence Staining
Immunofluorescence staining was conducted as reported previously [16] [17] [18] . In brief, for all immunofluorescence procedures, cultured cells were fixed in 4 % paraformaldehyde for 15 minutes. The cells were Fluorescence was recorded with a confocal laser microscope (Carl Zeiss, Jena, Germany). Appropriate control antibodies (each isotype-matched negative control: mouse, rabbit, rat IgG, Dako) were included in all experiments. We counted at least 200 cells in each experiment to calculate the cells expressing skeletal muscle cell associated proteins in vitro. Each percentage of the positive cells in immunofluorescence study was expressed by mean and standard error of the mean (s. e. m.) of at least three independent experiments.
Myoblast Transplantation to Mouse Anterior Tibial Muscle
We transplanted the myoblasts cultured with IG-FII only and IGFII plus SHH. We injected cultured cells at Day 3 (5x10 5 cells) into bilateral anterior tibial muscles of six-to eight-week-old C57BL6 (B6) mice. Dexamethasone (0.5-1.0 mg/kg, Sigma, Tokyo, Japan) was administered before transplantation, and cyclosporine (15-75 mg/kg, Novartis pharma K.K.) was administered daily. We increased the dose of cyclosporine because we observed severe rejection of transplanted cells. Our study was carried out in accordance with St. Marianna University School of Medicine's Animal Experiment Guidelines and was approved by the Animal Experiment Committee of the Experimental Animal Research Facilities, St. Marianna University School of Medicine (Approval No. TG-140514-1).
Results

Myoblast Induction from hiPS Cells
We examined myogenic gene expressions (MyoD, myogenin, Mrf4, and dystrophin) of undifferentiated hiPS cells and myoblasts at Day 7. Undifferentiated hiPS cells expressed mRNA of human MyoD and myogenin (Fig. 2) . Myoblasts cultured with IGFII expressed mRNA of human myogenin and dystrophin, but did not express mRNA of myoD and mrf4 at Day 7 (Fig. 2) . Myoblasts cultured with SHH expressed mRNA of human myoD and myogenin, but did not express mRNA of mrf4 and dystrophin at Day 7 (Fig. 2) . Myoblasts cultured with IGFII and SHH expressed mRNA of human myoD myogenin and dystrophin (Fig. 2) .
We next conducted immunostaining of the cultured myoblasts at Day 5, 7, and 11 to investigate whether the cells expressed proteins related to myogenesis.
Myoblasts at Day 5 expressed MyoD and the percentage of MyoD positive cells (MyoD positive cells / hNuc positive cells x100 %) was 29.1 ± 1.2 % (Fig. 3A, B , mean ± s. e. m. of three independent experiments). Myoblasts at Day 7 and 11 expressed MyoD protein and the percentages of MyoD positive cells were 53.5 ± 9.7 % and 22.4 ± 2.6 %, respectively (Fig. 3C-F) . Myoblasts at Day 5 did not ex- press myogenin ( Fig. 3G) . Myoblasts at Day 7 and 11 expressed myogenin and the percentages of myogenin positive cells were 26.3 ± 2.7 % and 4.0 ± 0.8 %, respectively ( Fig. 3H-K) . Mrf4 was expressed on the myoblasts at Day 5, 7, and 11, and percentages of mrf4 positive cells were 9.5 ± 1.5 %, 42.1 ± 7.2 %, and 60.0 ± 6.0 %, respectively (Fig.  3L-Q) . Myoblasts at Day 5 did not express dystrophin (Fig. 3R) . Myoblasts at Day 7 and 11 expressed dystrophin and percentages of dystrophin positive cells were 11.3 ± 2.3 % and 12.2 ± 3.8 %, respectively ( Fig. 3S-V) . These results suggested that SHH with IGFII supplementation successfully induced myogenic homeostasis from hiPS cells.
Analyses of Anterior Tibial Muscle Grafted with hiPS Cell Derived Myoblasts
Four days after transplantation (Fig. 1A) , we conducted histological (Fig. 4A-C, D-F, I -K, by hematoxylin and eosin staining) and immunohistochemical (Fig. 4G, H, L, M) analyses of cell-transplanted (n=8) and vehicle-injected muscle (n=3). The histopathological findings are summarized in Table  1 . In vehicle-injected control mice, we did not find any histological changes except for a small number of infiltrating cells (data not shown).
We did not detect transplanted grafts in the mice that were immunosuppressed with a conventional dose of cyclosporine and dexamethasone (mouse numbers 1-4 in Table 1 ). A massive infiltration of mouse immunocompetent cells was found in the lesion (Fig. 4A , mouse number 2 in Table 1 ). Mononuclear cell aggregations, including eosinophilic cells, were observed in the transplanted sites of several specimens (Fig. 4B, C) .
We observed transplanted cells diffusely in the transplanted site of mice immunosuppressed with dexamethasone only (mouse numbers 7-8 in Table  1 ). The histological findings of Fig. 4D-F and I-K were obtained from mouse number 8 in Table 1 . We analyzed the expressions of myogenic proteins in the area around the panels C and H of mouse number 8 (Fig. 4G, H, L, M) . We observed myoD (Fig. 4G, H and Table 1 ), myogenin ( Table 1) , and dystrophin (Fig. 4L, M and Table 1 ) positive human myoblasts focally in the transplanted site.
The expressions of MyoD and dystrophin (Fig.  4G, H, L, M) were remarkably reduced compared with those in in vitro culture (Fig. 3E, F, U, V) .
Discussion
Skeletal muscle transplantation is thought to be an effective treatment for massive muscle defects. However, autologous muscle cells show limited potential for ex vivo expansion 8) . Alternate cell sources are needed to achieve effective transplantation in patients with massive muscle defects.
In the current study, we utilized SHH to regulate the rapid and immature myogenesis of hiPS cells. We cultured the cells with SHH and IGFII after EB formation. We successfully generated dystrophin expressing cells in vitro (Fig. 3S-V) and transplanted the myoblasts into the mouse anterior tibial muscle. We observed severe inflammation of the transplanted site accompanied by massive infiltrations of host immunocompetent cells despite the administration of immunosuppressant (Fig. 4A-C) .
SHH is expressed in embryo 12) and adult 19) myoblasts and promotes their proliferation. In the study of molecular interactions of embryonic development, SHH simultaneously activates Smoothened (Smo) and PI3K/Akt pathway 19) . Smo is defined as a G protein-coupled receptor and one of the most important activators of SHH target genes 20) . We previously observed that IGFII promoted myocyte homeostasis in mouse ES 5) and hiPS cells 7) through PI3K/Akt signaling pathway. It was reported that SHH and IGFI cooperate in promoting myogenic differentiation and proliferation of adult myoblasts through both PI3K/Akt pathway and smo activation 21) . Both IGFI and IGFII bind IGFI receptor and share common features in the cell signaling 21) . Smo gene deletion blunted the IGFI effects on myogenic differentiation of myoblasts 21) . IGFI receptor had functional associations with Smo in response to both SHH and IGFI 21) . It was suggested that the integration of SHH and IGFI at the receptor level played a role in the myogenesis 21) . These data were consistent with the results of the current study which showed that SHH addition further promoted myogenesis of our favorable culture condition for inducing myoblasts from hiPS cells in the presence of IGFII (Fig. 2) 
7)
. We have previously reported that IGFII-transfected hiPS cells started to express dystrophin gene at Day 7 and dystrophin protein at Day 14 from the initiation of cell differentiation 7) . Pax7-transfected hiPS cells started to express dystrophin protein at Day 7 9) . In the current study, we observed that differentiated hiPS cells expressed dystrophin gene and protein at Day 7. Table 1 .
We did not detect transplanted grafts in the mice that were immunosuppressed with a conventional dose of cyclosporine (mouse numbers 1-4 in Table 1 ).
(A) Massive infiltration of mouse immunocompetent cells was found in the lesion (mouse number 2 in Table 1 ).
(B, C) Higher magnification of panels A and B inset, respectively. Mononuclear cell aggregations, including eosinophilic cells, were observed in the transplanted sites of several specimens.
(D-M) We observed the transplanted cells diffusely in the transplanted site of mice immunosuppressed with dexamethasone only (mouse numbers 7 and 8 in Table 1 ).
(D-F, I-K) Histological findings obtained from mouse number 8 in Table 1 . As mentioned previously, transcriptional factor Pax7 plays a role in early myogenesis through the regulation of satellite cells 2) . We suggest that SHH supplementation rapidly induced myogenesis in hiPS cells to the same extent as Pax7 transfection. The SHH supplementation did not decrease the cell viability of .
Withdrawal of the immunosuppressant drugs demonstrated that transplanted myoblasts were rapidly rejected with CD4+, CD8+ T cell and macrophage infiltration in the transplanted site within 7 days 25)26) . We observed that eosinophilic cells accumulated at the center of the transplanted site, surrounded by a large amount of mononuclear cells in a mouse with traditional dose administration of cyclosporine (Fig.  4C) . Eosinophil infiltration of transplanted organs is a good predictor of acute rejection in human cardiac 27) , lung 28) , and liver transplantation 29) . In the current study, infiltrating mouse immunocompetent cells decreased and surviving human cells increased to some extent by an increase in cyclosporine dose ( Table 1) . High dose administration of corticosteroid without cyclosporine remarkably improved the cell rejection ( 30) . We suggest that IGFII supplementation in the cell culture of hiPS cells may have a relationship with the weak effects of cyclosporine. Under the favorable immunosuppression status with dexamethasone, we observed reduced expressions of myogenic proteins in the lesion compared with those in in vitro cell culture. Clearly, we need to develop and optimize methods to reduce the host immunoreaction.
Conclusions
A combination of SHH, IGFII and EB formation of hiPS cells may be responsible for the promotion of myogenesis and mature skeletal muscle cells. Further studies are needed to characterize the underlying molecular mechanisms of transplanted myoblasts derived from hiPS cells for the formation of mature human skeletal muscle.
